KTP Project Awarded "Outstanding" Grade

lipolife, a leading, innovative brand in liposomal health supplements, is proud to announce that it has been awarded an “Outstanding” grade by Innovate UK for its Knowledge Transfer Partnership (KTP) with Anglia Ruskin University. This prestigious recognition underscores our commitment to advancing scientific excellence and innovation in liposomal technology.

Innovate UK, the UK’s innovation agency, assesses KTPs across the country, awarding grades from “Satisfactory” to “Outstanding” based on the partnership’s success in achieving significant business and academic benefits.

This project, in collaboration with Anglia Ruskin University, has demonstrated exceptional progress and impact, earning the highest possible accolade.

About the Knowledge Transfer Partnership

The KTP between lipolife and Anglia Ruskin University was initiated to enhance the development and efficacy of liposomal supplements through cutting-edge research and technology transfer.  Over the course of the partnership, the team focused on several key objectives:

– Innovation in Liposomal Delivery:
*Developing new methods to improve the bioavailability and stability of liposomal formulations.

– Advanced Analytical Techniques:
* Implementing state-of-the-art analytical techniques to ensure the highest quality and efficacy of liposomal products.

– Product Development:
*Expanding the lipolife product range with scientifically validated formulations targeting various health concerns.

KTP supervisor Mohammad Najlah, Professor of Pharmaceutical and Nano Medicine, said:

“The Knowledge Transfer Partnership has been a transformational journey for my research and created unbelievable opportunities for me to link with industry, develop my ideas and use my knowledge and expertise in collaboration with an industry partner to translate research from lab bench to store shelves.”

Gareth Meyer, GMPriority Pharma CEO, explains the impact of the KTP on the company:

“The experience and knowledge gained through the knowledge transfer partnership (KTP) has been instrumental in helping to shape the business’ strategic approach to market growth. The KTP has also instilled a renewed enthusiasm and drive for developing new, innovative products for market.”

Impact and Future Directions

The “Outstanding” grade from Innovate UK highlights the significant advancements made through the KTP and the positive impact on the product and service offerings of GMPriority Pharma. These achievements have not only strengthened the market position of lipolife but also set new standards for the industry.